5% stakes
Baker Bros. Advisors
Institution
- 5% stake reports
- 46
- 5% stake stocks
- 23
- Latest report
- 26/09/30
5% stake reports
| Stock | ||
|---|---|---|
| Kodiak Sciences KOD09/30 | 35%22,049,297 sh | +2.2pp |
| BeOne Medicines ONC09/16 | 7.8%115,912,814 sh | −0.2pp |
| Ideaya Biosciences IDYA08/14 | 5.2%5,010,030 sh | First report |
| Revolution Medicines RVMD08/14 | 5.3%11,443,357 sh | +0.4pp |
| Immatics IMTX08/14 | 7%9,508,565 sh | −3.0pp |
| Edgewise Therapeutics EWTX08/14 | 3.4%3,701,719 sh | −3.5pp |
| Cerus CERS08/14 | 3.2%6,415,295 sh | −2.0pp |
| Replimune Group REPL08/11 | 11.8%11,075,336 sh | −2.5pp |
| Celcuity CELC07/16 | 9.99%4,877,963 sh | +0.0pp |
| Celcuity CELC07/16 | 9.99%4,877,963 sh | −10.0pp |
| BeOne Medicines ONC06/15 | 8%115,912,814 sh | +0.0pp |
| Kiniksa Pharmaceuticals International KNSA05/26 | 7%3,253,341 sh | No earlier report |
| Monte Rosa Therapeutics GLUE05/15 | 9.99%8,876,346 sh | +3.3pp |
| Grail GRAL05/15 | 9.8%4,028,614 sh | +4.5pp |
| Kala BIO KALA05/15 | 0.01%2,312 sh | −10.0pp |
| Praxis Precision Medicines PRAX05/15 | 6.3%1,753,198 sh | First report |
| Incyte INCY05/11 | 15.6%31,225,572 sh | −0.1pp |
| Prelude Therapeutics PRLD04/22 | 15.5%10,295,301 sh | −8.0pp |
| BeOne Medicines ONC04/16 | 8%115,918,313 sh | No earlier report |
| Celcuity CELC03/24 | 19.99%9,582,874 sh | +1.1pp |
